Contribute Try STAT+ Today

On Tuesday, April 14th, Nicole Smith-Holt watched from the top balcony of the Minnesota state house as the legislature voted on the bill bearing her son’s name. A bill meant to prevent other Minnesotans from rationing their insulin and dying, like her son Alec did more than two years prior.

“Please don’t let this fall apart like last time,” Smith-Holt thought as she clutched her hands into a prayer position. She knew the bill wasn’t perfect, but she had already seen Alec’s bill fail once before. This was the best Minneosta was going to do anytime soon, she thought. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.